News Opinion Fellow Talk Why I Chose a Career in Interventional Cardiology Lowie Van Assche, MD September 05, 2018
News Conference News ESC 2018 Updated ESC Guidelines Introduce Concept of a Pregnancy Heart Team for Women With CVD Todd Neale August 31, 2018
News Conference News ESC 2018 Weight-Loss Drug Lorcaserin Clears Cardiovascular Safety Hurdle: CAMELLIA-TIMI 61 Michael O'Riordan August 26, 2018
News Daily News Global Longitudinal Strain May Help Predict Need for Early Intervention in Asymptomatic Severe AS L.A. McKeown August 20, 2018
News Daily News Best-Yet Study of Footballers Raises New Questions Over Preparticipation Cardiac Tests for Athletes Michael O'Riordan August 09, 2018
News Daily News ‘We Have to Go to Them’: New Global Initiative for Treating Rheumatic Heart Disease Michael O'Riordan August 06, 2018
News Daily News STS Data: Mitral Valve Cases Are Fastest-Growing CV Surgical Intervention in North America L.A. McKeown July 25, 2018
News Daily News Updated TAVR Consensus Statement Keeps Volume Requirements but Shifts Focus to Quality Todd Neale July 18, 2018
News Daily News Hemodynamic Deterioration Post-SAVR: Dysmetabolic Profile, Calcification Could Be Early Warning Signs Caitlin E. Cox July 10, 2018
News Daily News Lp(a) Might Not Be Good at Predicting Incident CVD in Low-Risk Women Yael L. Maxwell July 09, 2018
News Daily News CMS Taking Another Look at Volume Requirements for TAVR Programs Todd Neale June 28, 2018
News Industry News Edwards Comments On CMS Initiation Of National Coverage Analysis For TAVR June 28, 2018
News Conference News The Structural Heart Disease Summit 2018 Trade-offs Between Self-Expanding and Balloon-Expandable Valves in Very Large Annuli Michael O'Riordan June 26, 2018
News Industry News Essential Medical Announces Positive Results from The Safe Manta Clinical Trial, The First Pivotal Trial for a Dedicated Large Bore Closure Device June 25, 2018
News Conference News The Structural Heart Disease Summit 2018 SAFE-MANTA: Large-Bore Vascular Closure Device Achieves Fast Hemostasis With Few Complications Michael O'Riordan June 23, 2018
News Conference News The Structural Heart Disease Summit 2018 PORTICO I Postapproval Registry Outside the US Offers ‘Teaser’ for Pivotal Trial Shelley Wood June 23, 2018
News Conference News The Structural Heart Disease Summit 2018 High-Quality TAVR: Does a Minimum Volume Requirement Still Make Sense? Michael O'Riordan June 22, 2018
News Conference News The Structural Heart Disease Summit 2018 Data or Money: What’s Holding Back Cerebral Embolic Protection in TAVR? Shelley Wood June 21, 2018
News Conference News The Structural Heart Disease Summit 2018 Nearly 25% of AVR Patients Experience Anxiety or Depression in First Year Michael O'Riordan June 21, 2018